CareDx Inc (CDNA) - Product Pipeline Analysis, 2024 Update

CareDx Inc (CDNA) - Product Pipeline Analysis, 2024 Update


Summary

CareDx Inc (CareDx) is a diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. Its products include AlloSure, AlloMap, Qtype, Olerup SSP and SBT, Trusight, AlloSeq cfDNA, HeartCare, KidneyCare, Ottr Organ, Ottr Cellular, XynQAPI, TxAccess, XynCare, AlloCare, AlloCell and AlloSeq HCT. The company provides laboratory products along the pre and post-transplant testing continuum including human leukocyte antigen typing kits and testing solutions. CareDx offers novel surveillance management solutions to transform long-term patient care in transplantation. Its services also include digital transplant solutions, cell transplant therapy, pharma services, patient care management, and others. The company operates in the US, Sweden, and Australia. CareDx is headquartered in South San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company CareDx Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


CareDx Inc Company Overview
CareDx Inc Company Snapshot
CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview
CareDx Inc – Pipeline Analysis Overview
CareDx Inc - Key Facts
CareDx Inc - Major Products and Services
CareDx Inc Pipeline Products by Development Stage
CareDx Inc Ongoing Clinical Trials by Trial Status
CareDx Inc Pipeline Products Overview
AI-Enabled Cardiac Allograft Vasculopathy (CAV) Scoring Tool
AI-Enabled Cardiac Allograft Vasculopathy (CAV) Scoring Tool Product Overview
AiKidney
AiKidney Product Overview
AlloHeme Liver
AlloHeme Liver Product Overview
AlloHeme Liver Clinical Trial
AlloID
AlloID Product Overview
AlloID Clinical Trial
AlloMap Liver
AlloMap Liver Product Overview
AlloSeq BMT
AlloSeq BMT Product Overview
AlloSure - BKV-Associated Nephropathy (BKVAN)
AlloSure - BKV-Associated Nephropathy (BKVAN) Product Overview
AlloSure Liver
AlloSure Liver Product Overview
Clinical Decision Support Tool
Clinical Decision Support Tool Product Overview
Diagnostic Test - Crohn's Disease
Diagnostic Test - Crohn's Disease Product Overview
Diagnostic Test - Multiple Sclerosis
Diagnostic Test - Multiple Sclerosis Product Overview
Diagnostic Test - Rheumatoid Arthritis
Diagnostic Test - Rheumatoid Arthritis Product Overview
Diagnostic Test - Sjogren's Syndrome
Diagnostic Test - Sjogren's Syndrome Product Overview
Diagnostic Test - Systemic Lupus Erythematosus
Diagnostic Test - Systemic Lupus Erythematosus Product Overview
HistoMap
HistoMap Product Overview
HistoMap Clinical Trial
HistoMap Liver
HistoMap Liver Product Overview
Post Transplant Management-Lung Transplant
Post Transplant Management-Lung Transplant Product Overview
UroMap
UroMap Product Overview
CareDx Inc - Key Competitors
CareDx Inc - Key Employees
CareDx Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
CareDx Inc, Recent Developments
May 29, 2024: Caredx Reiterates Position That It Does Not Infringe The ‘544 Patent, Injunction Motion Is Irrelevant
May 16, 2024: Landmark Study Shows CareDx’s Heartcare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
Apr 16, 2024: CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
Apr 09, 2024: CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
Feb 27, 2024: Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests
Feb 21, 2024: CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
Jan 26, 2024: CareDx Issues Statement in Patent Infringement Case
Jan 11, 2024: Caredx Adds to Allosure Kidney and Heartcare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
Dec 19, 2023: CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: CareDx Inc Pipeline Products by Equipment Type
Table 3: CareDx Inc Pipeline Products by Indication
Table 4: CareDx Inc, Key Facts
Table 5: CareDx Inc, Major Products and Services
Table 6: CareDx Inc Number of Pipeline Products by Development Stage
Table 7: CareDx Inc Pipeline Products Summary by Development Stage
Table 8: CareDx Inc Ongoing Clinical Trials by Trial Status
Table 9: CareDx Inc Ongoing Clinical Trials Summary
Table 10: AI-Enabled Cardiac Allograft Vasculopathy (CAV) Scoring Tool - Product Status
Table 11: AI-Enabled Cardiac Allograft Vasculopathy (CAV) Scoring Tool - Product Description
Table 12: AiKidney - Product Status
Table 13: AiKidney - Product Description
Table 14: AlloHeme Liver - Product Status
Table 15: AlloHeme Liver - Product Description
Table 16: AlloHeme Liver - AlloSure Lung Assessment and Metagenomics Outcomes Study
Table 17: AlloHeme Liver - Assessment of Chimerism and Relapse Post Bone Marrow/HCT Transplant Using AlloHeme Test (ACROBAT)
Table 18: AlloID - Product Status
Table 19: AlloID - Product Description
Table 20: AlloID - AlloSure Lung Assessment and Metagenomics Outcomes Study
Table 21: AlloMap Liver - Product Status
Table 22: AlloMap Liver - Product Description
Table 23: AlloSeq BMT - Product Status
Table 24: AlloSeq BMT - Product Description
Table 25: AlloSure - BKV-Associated Nephropathy (BKVAN) - Product Status
Table 26: AlloSure - BKV-Associated Nephropathy (BKVAN) - Product Description
Table 27: AlloSure Liver - Product Status
Table 28: AlloSure Liver - Product Description
Table 29: Clinical Decision Support Tool - Product Status
Table 30: Clinical Decision Support Tool - Product Description
Table 31: Diagnostic Test - Crohn's Disease - Product Status
Table 32: Diagnostic Test - Crohn's Disease - Product Description
Table 33: Diagnostic Test - Multiple Sclerosis - Product Status
Table 34: Diagnostic Test - Multiple Sclerosis - Product Description
Table 35: Diagnostic Test - Rheumatoid Arthritis - Product Status
Table 36: Diagnostic Test - Rheumatoid Arthritis - Product Description
Table 37: Diagnostic Test - Sjogren's Syndrome - Product Status
Table 38: Diagnostic Test - Sjogren's Syndrome - Product Description
Table 39: Diagnostic Test - Systemic Lupus Erythematosus - Product Status
Table 40: Diagnostic Test - Systemic Lupus Erythematosus - Product Description
Table 41: HistoMap - Product Status
Table 42: HistoMap - Product Description
Table 43: HistoMap - AlloSure Lung Assessment and Metagenomics Outcomes Study
Table 44: HistoMap Liver - Product Status
Table 45: HistoMap Liver - Product Description
Table 46: Post Transplant Management-Lung Transplant - Product Status
Table 47: Post Transplant Management-Lung Transplant - Product Description
Table 48: UroMap - Product Status
Table 49: UroMap - Product Description
Table 50: CareDx Inc, Key Employees
Table 51: CareDx Inc, Subsidiaries
Table 52: Glossary
List of Figures
Figure 1: CareDx Inc Pipeline Products by Equipment Type
Figure 2: CareDx Inc Pipeline Products by Development Stage
Figure 3: CareDx Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings